Dose-Ranging Study of A006 DPI, in Adult Asthma Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01174732
Recruitment Status : Completed
First Posted : August 4, 2010
Last Update Posted : April 19, 2017
Information provided by (Responsible Party):
Amphastar Pharmaceuticals, Inc.

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : October 2010
  Actual Study Completion Date : January 2011
  Certification/Extension First Submitted : April 17, 2017